Clinical operations note: medical-device-vendor-evaluation-a-6step-checklist-to-avoid-procurement-mistakes-141

I'm a supply chain manager handling medical device procurement for a 14-bed ambulatory surgical center. Over the last six years, I've personally made and documented 11 significant buying mistakes, totaling roughly $180,000 in wasted budget—or maybe $185,000, I'd have to check with finance. Either way, too much.

I now maintain our team's vendor evaluation checklist. This guide is for anyone purchasing or leasing medical equipment—hospitals, outpatient surgery centers, clinic administrators. These six steps would have saved me a lot of pain (and budget) early on.

One caveat: this works best for significant purchases or new vendor relationships. It's probably overkill for routine reorders of standard consumables. And this worked for us because we're a mid-size surgical center with a lean purchasing team. If you have a dedicated clinical engineering department, your process might not need to go quite this deep.

Step 1: Map the Company's Corporate Structure and Recent History

The first thing I check is corporate health. Mergers, acquisitions, and product line decisions affect your purchase more than most buyers expect.

Take Globus Medical's merger with NuVasive as an example. When you evaluate Globus Medical, the NuVasive merger is worth understanding. Which products from the NuVasive portfolio continued? Which were folded into Globus Medical's broader spine and surgical offering? How did the integration affect customer support and rep coverage? Mergers like this change sales territories, service contracts, and product availability—all things that matter to your facility.

Take twenty minutes to search for recent announcements—for example, "globus medical news october 2025"—and open their investor relations page. You're looking for signs of instability, roadmap pivots, or leadership changes that could affect your purchase.

I learned this the hard way in September 2022. We evaluated a small imaging company with competitive pricing and reasonable lead times. What we didn't dig into: a larger manufacturer had acquired them a year earlier. Six months after our purchase, the product line was discontinued. $12,000 gone, plus the time we lost sourcing a replacement. That's when the corporate history check became step one.

Step 2: Understand How the Technology Works Before You Compare Specs

Here's the thing: most buyers skip this step because it requires real effort. You can't evaluate spec sheets if you don't understand what the device actually does in your clinical setting.

Let's say your facility is exploring renal care and you're looking at dialysis equipment. You need a baseline understanding of how hemodialysis works before you talk to vendors. In short: the patient's blood is drawn through a vascular access point—typically a fistula in the arm—and pumped into a dialyzer, which acts as an artificial kidney. Inside the dialyzer, thousands of tiny hollow fibers form a semipermeable membrane. Blood flows through the fibers while dialysate, a balanced solution of water, electrolytes, and bicarbonate, flows around them. Waste products such as urea and creatinine diffuse from the blood into the dialysate down their concentration gradient. Excess fluid is pulled across the membrane by pressure; that's ultrafiltration. The cleaned blood returns to the patient, and the used dialysate drains away.

If you don't know these fundamentals, you won't know which questions to ask. You won't be able to judge whether a manufacturer's claims about ultrafiltration accuracy or membrane performance actually align with your clinical needs.

From the outside, vendor evaluation looks like comparing spec sheets and prices. The reality is you need to understand the technology's role in your workflow first. In my first year (2019), I ordered patient monitors with advanced parameter modules our team never used, because I was comparing feature checkboxes, not care processes. $8,900 wasted. Not ideal.

Step 3: Verify Infection Control Credentials

For any device that touches a patient, infection control is non-negotiable. That includes surgical instruments, patient monitors, and dedicated infection control products such as disinfectants or sterilization wraps.

Here's what I check now:

• Can the device be cleaned with your facility's standard disinfectants? Check chemical compatibility—not just whether they "should" work.
• What sterilization cycles does it support, if applicable? Flash, ETO, hydrogen peroxide plasma?
• Which components are single-use? Those become recurring costs that belong in your total cost calculation.
• Has the manufacturer published reprocessing validation data, or are you getting a one-page instruction sheet?

Per CDC's Guideline for Disinfection and Sterilization in Healthcare Facilities, reprocessing requires validated instructions. If a vendor can't provide that data, consider it a red flag.

My lesson came during a 2021 state audit. Our device cleaning documentation got flagged because the manufacturer's reprocessing instructions were vague. We couldn't prove we were following the required process. The citation wasn't a fine, but it cost us credibility—and a lot of weekend hours rewriting protocols. That's when infection control verification became a permanent step in our process.

To be fair, most vendors do provide reprocessing instructions. The depth varies dramatically. Some hand you a single page; some give you the full validation report. Guess which ones pass audits?

Step 4: Scrutinize Robotic Surgery System Claims

Robotic surgery systems represent one of the largest procurement risks in the medical device space. Major capital investment, training requirements, and integration complexities make them a category where mistakes are expensive.

From the outside, every robotic surgery system looks roughly similar: a computer assists the surgeon with precision. The reality is the workflow, learning curve, and OR integration requirements differ substantially between platforms.

Here's what I ask vendors now:

• What is the navigation accuracy, and under what conditions is it actually maintained? Ask for the technical specifications, not the marketing slides.
• What does the training pathway look like? How many cases does a surgeon need to reach proficiency, and what support is provided during that period?
• What are the annual recurring costs? Software licenses, service contracts, consumables, staff re-training.
• How does the system integrate with your existing imaging and OR table setup? Compatibility surprises are expensive.

There are systems designed for different surgical workflows. Globus Medical's ExcelsiusGPS, for example, is a robotic navigation system for spine surgery, where the robotic arm assists in accurate instrument and implant placement aligned to the patient's anatomy. Whether that's the right fit for you depends on your case mix, surgeon experience, and OR environment.

I have mixed feelings about robotic systems generally. The precision and data capture are genuinely valuable. On the other hand, the total cost of ownership is considerable, and I've personally watched equipment sit underutilized because the purchase decision ran ahead of the training plan. Part of me wants to tell every surgical center to wait until a clear clinical need exists. Another part recognizes that building familiarity takes time, and delaying too long has its own cost.

Step 5: Check Regulatory Clearance and Reimbursement Before You Sign

Regulatory status and reimbursement pathways determine whether a device becomes an asset or a liability. Check both before committing.

Search the FDA's 510(k) database for the specific product. Read the cleared indication, not just the product name. If the indication doesn't match the way you intend to use it, that's a problem.

Reimbursement is the area I missed in 2019. I purchased a device with FDA clearance but no viable coverage pathway. A grant funded the first six months; after that, no reimbursement meant no utilization. The equipment sat unused while we paid off the lease. Worse than expected.

This is why regulatory and reimbursement support from the vendor matters. Some companies, including Globus Medical, list FDA codes and reimbursement assistance as part of their offering. When you evaluate a vendor, ask directly: "Which CPT codes and coverage policies apply to this product, and what evidence can you provide?" If the answer is vague, walk away.

Step 6: Pressure-Test Service and Support Commitments

The most cost-effective equipment is worthless if it's down for three weeks waiting for a service engineer.

Get the service team on the phone during the evaluation phase and ask:

• What is the expected uptime or mean time to repair?
• Where are your service engineers located, and what response time is guaranteed in the contract?
• Is staff training included, and for how many people? What does additional training cost?
• What does the service contract exclude? They all exclude something.

Our first service contract looked comprehensive—until our ultrasound system failed at 6 AM on a Saturday. The on-call engineer needed parts that weren't stocked locally, and we waited over four days. We rescheduled 11 procedures. The contract technically complied with its response-time clause. That's when I started reading service agreements line by line.

Common Mistakes I Still See in Medical Device Procurement

I keep a list of recurring mistakes, partly because they echo my own:

• Shopping on the lowest quoted price. It's rarely the lowest total cost once you include training, service, consumables, and downtime.
• Skipping clinical input. Your surgeons, nurses, and technicians will spot problems your spreadsheet doesn't. Include them in the demo.
• Ignoring the corporate roadmap. Ask: "What's the expected lifecycle of this product, and what's the migration path if it's discontinued?"
• Trusting the controlled demo. Ask to see the device functioning in a real clinical environment, ideally during the procedure you're planning to use it for.

This checklist is the product of 11 documented failures and a fair amount of budget I won't get back. Since we started using it in Q1 2024, our team has caught 47 potential issues before they became purchase orders. It'll probably catch a few for you, too.